Table: Pharmarise Holdings -2018/19 group results

Pharmarise Holdings

16/07/2019 10:30

Jul 16 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to        NEXT     
                May 31, 2019    May 31, 2018   May 31, 2020      YEAR       
                   LATEST         YEAR-AGO        COMPANY        COMPANY    
                   RESULTS         RESULTS       FORECAST      H1 FORECAST  
  Sales             51.73           54.56          52.51          26.10     
                 (-5.2 pct)      (+3.0 pct)     (+1.5 pct)     (+1.7 pct)   
  Operating        640 mln           1.18         858 mln        240 mln    
                 (-45.7 pct)    (+166.3 pct)    (+34.1 pct)    (+37.9 pct)  
  Recurring        590 mln           1.09         787 mln        203 mln    
                 (-45.9 pct)    (+236.9 pct)    (+33.2 pct)    (+64.9 pct)  
  Net
  Net              23 mln        loss 28 mln      104 mln      loss 96 mln  
                                               (+349.7 pct)                 
  EPS             2.55 yen      loss 3.19 yen    10.98 yen   loss 10.07 yen 
  EPS Diluted     2.24 yen                                                  
  Ann Div         14.00 yen       14.00 yen      14.00 yen                  
  -Q2 Div            NIL             NIL            NIL                     
  -Q4 Div         14.00 yen       14.00 yen      14.00 yen                  
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T